---
title: 'Ars Live: The rise of GLP-1 drugs: Insights and Unknowns'
link: https://www.youtube.com/watch?v=eLI6dYmtmGo
source: youtube-com-arstechnica
published: 2024-10-30T14:54:22Z
updated: 2026-05-21T02:30:19Z
first_seen: 2026-09-08T10:17:10.166315Z
authors:
- Ars Technica
summary: Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.
content: extracted
html: 2024-10-30-ars-live-the-rise-of-glp-1-drugs-insights-and-unknowns.html
preview:
  file: 2024-10-30-ars-live-the-rise-of-glp-1-drugs-insights-and-unknowns.preview-84896d0dd0fe.webp
  width: 256
  height: 192
  color: '#110e0f'
images:
- source: https://i.ytimg.com/vi/eLI6dYmtmGo/maxresdefault.jpg
  original:
    file: 2024-10-30-ars-live-the-rise-of-glp-1-drugs-insights-and-unknowns.image-c9703b4d3588.jpg
    width: 1280
    height: 720
  variants:
  - file: 2024-10-30-ars-live-the-rise-of-glp-1-drugs-insights-and-unknowns.image-33aca815ef44.webp
    width: 48
    height: 27
  color: '#010306'
extra:
  thumbnail: https://i2.ytimg.com/vi/eLI6dYmtmGo/hqdefault.jpg
---

Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.